PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes

PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes

Reprogramming of energy metabolism is a key hallmark of cancer, which provides a new research perspective for exploring the development of cancer. However, the most critical target of anti-glycolytic therapy for ovarian cancer remains unclear. Therefore, in the present study, Oncomine, GEPIA, and HP...

Full description

Bibliographic Details
Main Authors: Rui Gou, Yuexin Hu, Ouxuan Liu, Hui Dong, Lingling Gao, Shuang Wang, Mingjun Zheng, Xiao Li, Bei Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
PGK1
Warburg effect
ovarian cancer
anti-glycolytic therapy
NG52
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.682461/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.682461/full

Similar Items